Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-33
Closed -$2.36K 1499
2023
Q4
$2.36K Hold
33
﹤0.01% 1184
2023
Q3
$2.29K Buy
33
+14
+74% +$1.06K ﹤0.01% 1147
2023
Q2
$1.54K Buy
+19
New +$1.55K ﹤0.01% 1223
2020
Q1
Sell
-111
Closed -$6K 1146
2019
Q4
$6K Hold
111
﹤0.01% 792
2019
Q3
$6K Buy
111
+7
+7% +$344 ﹤0.01% 774
2019
Q2
$5K Hold
104
﹤0.01% 767
2019
Q1
$5K Hold
104
﹤0.01% 648
2018
Q4
$4K Sell
104
-28
-21% -$1.15K ﹤0.01% 736
2018
Q3
$5K Hold
132
﹤0.01% 735
2018
Q2
$5K Hold
132
﹤0.01% 722
2018
Q1
$5K Hold
132
﹤0.01% 725
2017
Q4
$6K Buy
+132
New +$5.26K ﹤0.01% 666
2017
Q3
Sell
-104
Closed -$5K 436
2017
Q2
$5K Hold
104
﹤0.01% 570
2017
Q1
$4K Hold
104
﹤0.01% 637
2016
Q4
$4K Hold
104
﹤0.01% 574
2016
Q3
$4K Hold
104
﹤0.01% 558
2016
Q2
$4K Hold
104
﹤0.01% 547
2016
Q1
$4K Hold
104
﹤0.01% 564
2015
Q4
$4K Buy
+104
New +$4.05K ﹤0.01% 519
2014
Q1
Sell
-1,000
Closed -$22K 574
2013
Q4
$22K Buy
+1,000
New +$22K 0.01% 292
2013
Q3
Sell
-340
Closed -$7K 543
2013
Q2
$7K Buy
+340
New +$7.1K ﹤0.01% 286

Other funds holding HOLX

Gradient Investments's HOLX Position: Q1 2024 in Review

Gradient Investments sold out of Hologic (HOLX) in Q1 2024, closing a stake of 33 shares — an estimated $2.36K sold.

Gradient Investments first reported a position in HOLX in Q2 2013 and held it in 21 quarters. The position peaked at $22K in Q4 2013. 705 funds tracked by Wall St. Rank hold HOLX as of Q1 2024.

  • Gradient Investments reported no remaining Hologic position as of Q1 2024 after selling out during the quarter.
  • Gradient Investments sold 33 Hologic shares in Q1 2024, an estimated $2.36K.
  • Gradient Investments first reported a position in Hologic in Q2 2013 and held it in 21 quarters.
  • Gradient Investments's Hologic position peaked at $22K in Q4 2013.
  • 705 funds tracked by Wall St. Rank held Hologic as of Q1 2024.

Based on Gradient Investments's 13F filing for Q1 2024, filed 23 Apr 2024.